Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.

K Abe1, M Takanashi, Y Watanabe

  • 1Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan. abe@neurol.med.osaka-u.ac.jp

Neuroradiology
|August 22, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells.

Biochemical and biophysical research communications·1992
Same author

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Journal of medicinal chemistry·1992
Same author

Substance P induces intracellular calcium increase and translocation of protein kinase C in epidermis.

The British journal of dermatology·1992
Same author

Interleukin-2 production by primary adult T cell leukemia tumor cells is macrophage dependent.

American journal of hematology·1992
Same author

Deletion of mitochondrial DNA in the endomyocardial biopsy sample from a patient with Kearns-Sayre syndrome.

European heart journal·1992
Same author

Entrainment to external Ca2+ oscillation in ionophore-treated Physarum plasmodium.

Cell structure and function·1992

N-acetylaspartate (NAA), a neuronal marker, is reduced in the brains of patients with amyotrophic lateral sclerosis (ALS). Reduced NAA levels in the motor area and frontal lobe correlate with disease severity and cognitive function.

Area of Science:

  • Neuroscience
  • Neurology
  • Biochemistry

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
  • N-acetylaspartate (NAA) is a key marker of neuronal integrity.
  • Understanding neuronal loss in ALS is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate NAA levels in the brains of ALS patients using magnetic resonance spectroscopy (MRS).
  • To determine the correlation between NAA levels and clinical features, including motor function and frontal lobe function.
  • To assess NAA as a potential biomarker for neuronal damage in ALS.

Main Methods:

  • 1H magnetic resonance spectroscopy (MRS) was used to measure NAA, creatine (Cr), and choline-containing compounds (Cho) in 14 ALS patients and 14 controls.

Related Experiment Videos

  • Disease severity was assessed using manual muscle strength tests and the Norris limb and bulbar scales.
  • Frontal lobe function was evaluated using the Wisconsin Card Sorting test.

    • Main Results:

    • The NAA/Cr ratio was significantly reduced in the motor area and frontal lobe of ALS patients compared to controls.
    • The Cho/Cr ratio remained normal across the brain in ALS patients.
    • Significant correlations were found between motor area NAA/Cr ratio and limb function (r=0.50), and frontal lobe NAA/Cr ratio and cognitive function (r=0.71).

    Conclusions:

    • Reduced NAA/Cr ratio serves as a biomarker for cortical neuronal loss in ALS.
    • NAA levels in specific brain regions correlate with disease progression and cognitive deficits.
    • MRS measurement of NAA holds potential for monitoring ALS progression and therapeutic efficacy.